New Botanical Supplement Launches in the United States
The product is derived from the caapi vine, and users must discuss potential medication interactions with a doctor.
Updated on Oct. 26, 2026 in Substance Abuse
Live Poll
Do you believe unregulated herbal supplements provide meaningful cognitive or mental health benefits?
Happy Caapi launched in July 2026 as a supplement derived from the Banisteriopsis caapi vine. While the product is marketed for mental well-being, it is formulated to exclude DMT, a Schedule I controlled substance in the United States.
Why it matters
The introduction of this vine-derived supplement highlights a growing consumer interest in botanical products for cognitive support. Because these extracts can interact with common mental health medications, understanding the ingredients and safety precautions is essential for consumers.
The manufacturer employs third-party laboratories to screen for pesticides, heavy metals, and the presence of DMT. While these tests confirm the absence of specific contaminants, the long-term biological effects of these vine-derived beta-carbolines remain unknown.
The players
Happy Caapi
A company that produces an oral supplement containing extracts from the Banisteriopsis caapi vine.
The details
Happy Caapi is manufactured using an extract of the Banisteriopsis caapi vine, which the company sources from a single traceable supplier in South America. The supplement contains beta-carbolines but is explicitly processed to be free of DMT. The manufacturer advises users to avoid combining the product with SSRIs, SNRIs, MAOIs, tramadol, DXM, or tyramine-rich foods to prevent potential adverse interactions.
Timeline
Happy Caapi officially launched in July 2026.
The product sold out at the Beyond Psychedelics conference in October 2026.
Health Landscape
The market entry of Happy Caapi represents a trend of companies navigating the complex regulatory environment surrounding botanical derivatives. It marks a distinct effort to offer plant-based mental support while remaining compliant with federal law regarding substances categorized under the Controlled Substances Act's Schedule I classification.
If you are currently taking prescription medications like SSRIs, SNRIs, or MAOIs, this product carries a high risk of adverse interaction. Any interest in using this or similar botanical supplements should be discussed with your physician to ensure it does not complicate your existing care plan.
The takeaway
The use of botanical extracts for cognitive health requires caution, particularly regarding potential interactions with prescription medications. Before starting any new supplement, check the ingredient list carefully and have a conversation with your healthcare provider about how it aligns with your health needs.
Further reading
For more information on the complexities of emerging supplements, visit the Substance Abuse section.
Source note: This article includes information reported by New York Post.
Live Poll
Do you believe unregulated herbal supplements provide meaningful cognitive or mental health benefits?
